Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Return on Sales (2020 - 2023)

Immuneering (IMRX) has 4 years of Return on Sales data on record, last reported at 115883.27% in Q3 2023.

  • For Q3 2023, Return on Sales fell 11554546.0% year-over-year to 115883.27%; the TTM value through Sep 2023 reached 115883.27%, down 11578796.0%, while the annual FY2022 figure was 159.37%, 14325.0% down from the prior year.
  • Return on Sales reached 115883.27% in Q3 2023 per IMRX's latest filing, down from 1355.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 6.44% in Q3 2020 and bottomed at 115883.27% in Q3 2023.
  • Average Return on Sales over 4 years is 12321.7%, with a median of 95.74% recorded in 2022.
  • Peak YoY movement for Return on Sales: crashed -1124bps in 2021, then crashed -11554546bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 6.44% in 2020, then tumbled by -798bps to 57.88% in 2021, then tumbled by -51047bps to 29601.85% in 2022, then crashed by -291bps to 115883.27% in 2023.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 115883.27% in Q3 2023, 1355.0% in Q2 2023, and 388.62% in Q1 2023.